The landmark interim trade agreement between India and the United States has fundamentally shifted the investment landscape, triggering a decisive risk-on sentiment for Indian equities. This historic reset, formalized in February 2026, has seen the US slash reciprocal tariffs on Indian goods from 25% down to 18%, while total duties on specific categories have plummeted from 50% to zero. The deal unlocks immediate access to a 30-trillion-dollar US market, providing a massive competitive edge for Indian exporters against regional peers. With India’s benchmark Nifty 50 currently trading at a price-to-earnings (P/E) ratio of approximately 22.7, valuations remain below long-term averages. This creates significant headroom for multiple expansion as earnings visibility improves across the board. The pharmaceutical sector is a primary beneficiary of the new framework. Indian generic drugs and active pharmaceutical ingredients (APIs) now enjoy zero-duty access to the US, insulating the 10-billion-dollar export pipeline from previous punitive measures. This clarity is expected to drive higher margins and sustained volume growth for domestic drugmakers. The gems and jewelry industry is also poised for a major rebound. Tariffs on Indian diamonds and jewelry have been reduced from 50% to 18%, while select high-value categories like polished diamonds and platinum now attract zero duty. This shift targets a US market valued at over 61 billion dollars, offering a direct boost to profitability for Indian exporters. Broader economic indicators reflect this newfound stability. Goldman Sachs recently upgraded India’s 2026 GDP growth forecast to 6.9% following the announcement. Furthermore, India’s current account deficit is projected to narrow by 0.25% of GDP, supported by record-high exports that reached 825.25 billion dollars in the last fiscal cycle. Investors are also monitoring a massive 500-billion-dollar purchasing commitment from India for US energy, aircraft, and technology products over the next five years. This strategic alignment is expected to unlock a private investment cycle and strengthen the Indian Rupee, which has already emerged as one of the best-performing emerging market currencies this month. With inflation stabilizing near the 4% target and rural consumption showing resilience, the equity market reset appears well-supported by fundamental data. The combination of lower trade barriers and robust corporate earnings creates a compelling window for capital allocation into India’s manufacturing and export-oriented sectors.